| Management of Helicobacter pylori infection—the Maastricht IV/Florence consensus report P Malfertheiner, F Megraud, CA O'Morain, J Atherton, ATR Axon, ... Gut 61 (5), 646-664, 2012 | 7613* | 2012 |
| Management of Helicobacter pylori infection—the Maastricht V/Florence consensus report P Malfertheiner, F Mégraud, CA O'Morain, JP Gisbert, EJ Kuipers, ... Gut 66 (1), 6-30, 2017 | 4145* | 2017 |
| Interleukin-1 polymorphisms associated with increased risk of gastric cancer EM El-Omar, M Carrington, WH Chow, KEL McColl, JH Bream, HA Young, ... Nature 404 (6776), 398-402, 2000 | 3183 | 2000 |
| Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment AD Kostic, E Chun, L Robertson, JN Glickman, CA Gallini, M Michaud, ... Cell host & microbe 14 (2), 207-215, 2013 | 2607 | 2013 |
| Kyoto global consensus report on Helicobacter pylori gastritis K Sugano, J Tack, EJ Kuipers, DY Graham, EM El-Omar, S Miura, ... Gut 64 (9), 1353-1367, 2015 | 2450 | 2015 |
| Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report P Malfertheiner, F Megraud, C O'morain, APS Hungin, R Jones, A Axon, ... Alimentary pharmacology & therapeutics 16 (2), 167-180, 2002 | 2155 | 2002 |
| Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms EM El-Omar, CS Rabkin, MD Gammon, TL Vaughan, HA Risch, ... Gastroenterology 124 (5), 1193-1201, 2003 | 1201 | 2003 |
| Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report P Malfertheiner, F Megraud, T Rokkas, JP Gisbert, JM Liou, C Schulz, ... Gut 71 (9), 1724-1762, 2022 | 1083* | 2022 |
| Host-bacterial interactions in Helicobacter pylori infection MR Amieva, EM El–Omar Gastroenterology 134 (1), 306-323, 2008 | 1022 | 2008 |
| IBD—what role do Proteobacteria play? I Mukhopadhya, R Hansen, EM El-Omar, GL Hold Nature reviews Gastroenterology & hepatology 9 (4), 219-230, 2012 | 796 | 2012 |
| Helicobacter pylori infection and chronic gastric acid hyposecretion EM El-Omar, K Oien, A El-Nujumi, D Gillen, A Wirz, S Dahill, C Williams, ... Gastroenterology 113 (1), 15-24, 1997 | 796 | 1997 |
| Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia K McColl, L Murray, E El-Omar, A Dickson, A El-Nujumi, A Wirz, A Kelman, ... New England Journal of Medicine 339 (26), 1869-1874, 1998 | 712 | 1998 |
| Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease EM El-Omar, ID Penman, JES Ardill, RS Chittajallu, C Howie, KEL McColl Gastroenterology 109 (3), 681-691, 1995 | 704 | 1995 |
| OLGA staging for gastritis: a tutorial M Rugge, P Correa, F Di Mario, E El-Omar, R Fiocca, K Geboes, ... Digestive and liver disease 40 (8), 650-658, 2008 | 610 | 2008 |
| Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? GL Hold, M Smith, C Grange, ER Watt, EM El-Omar, I Mukhopadhya World journal of gastroenterology: WJG 20 (5), 1192, 2014 | 511 | 2014 |
| Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy M Macarthur, GL Hold, EM El-Omar American Journal of Physiology-Gastrointestinal and Liver Physiology 286 (4 …, 2004 | 506 | 2004 |
| Genetics of gastric cancer MH McLean, EM El-Omar Nature reviews Gastroenterology & hepatology 11 (11), 664-674, 2014 | 491 | 2014 |
| Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan T Furuta, EM El–Omar, F Xiao, N Shirai, M Takashima, H Sugimurra Gastroenterology 123 (1), 92-105, 2002 | 487 | 2002 |
| Helicobacter pylori infection P Malfertheiner, MC Camargo, E El-Omar, JM Liou, R Peek, C Schulz, ... Nature reviews Disease primers 9 (1), 19, 2023 | 486 | 2023 |
| The importance of interleukin 1β inHelicobacter pylori associated disease EM El-Omar Gut 48 (6), 743-747, 2001 | 483 | 2001 |
